Transtheoretical model-based mobile health application for PCOS

Table 3 BMI, WC, SAS and SDS of change at baseline, 6-month and 12-month post-intervention among the PCOS patients

Measured parameter	Baseline	6-month	12-month	F(time*group)	P value
BMI				12.8	0.00**
Intervention group	25.99 ± 3.87	23.40 ± 1.69	22.63 ± 1.97
Control group	25.25 ± 3.95	25.36 ± 3.06	24.86 ± 2.65
t-value	0.89	− 3.7	6.55
P-value	0.38	0.00**	0.00**
WC				2.44	0.04*
Intervention group	86.22 ± 9.91	81.54 ± 8.54	80.50 ± 6.94
Control group	87.64 ± 6.59	86.75 ± 5.52	85.44 ± 7.95
t-value	− 0.79	− 3.44	− 3.14
P-value	0.43	0.00**	0.00**
SAS				0.91	0.016*
Intervention group	46.97 ± 6.53	42.91 ± 6.65	42.12 ± 9.69
Control group	49.02 ± 7.05	47.83 ± 6.27	46.46 ± 8.91
t-value	− 1.23	− 3.49	− 2.14
P-value	0.223	0.001**	0.035*
SDS				8.41	0.000***
Intervention group	51.55 ± 6.78	46.83 ± 5.36	40.57 ± 5.41
Control group	52.29 ± 6.86	50.57 ± 5.42	49.24 ± 7.14
t-value	0.5	− 2.72	− 6.24
P-value	0.621	0.008**	0.000***

F(time * group): The changing trend of measurement indicators in intervention group and control group at different intervention time points
BMI body mass index, WC Waist circumference, SAS Self Rating Anxiety Scale, SDS Self Rating Depression Scale
^* = P < 0.05;** = P < 0.01:*** = P < 0.001

ISSN: 1742-4755